Neuspera secures FDA approval for urinary incontinence implantable
The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for treating urinary urge incontinence (UUI). The post Neuspera secures FDA approval for urinary incontinence implantable appeared first on Medical Device Network.

The post Neuspera secures FDA approval for urinary incontinence implantable appeared first on Medical Device Network.